Gradient Investments’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-90
Closed -$2K 1258
2022
Q1
$2K Hold
90
﹤0.01% 1031
2021
Q4
$2K Hold
90
﹤0.01% 1060
2021
Q3
$2K Hold
90
﹤0.01% 999
2021
Q2
$2K Hold
90
﹤0.01% 991
2021
Q1
$2K Hold
90
﹤0.01% 998
2020
Q4
$2K Hold
90
﹤0.01% 952
2020
Q3
$2K Hold
90
﹤0.01% 957
2020
Q2
$2K Buy
+90
New +$2.09K ﹤0.01% 877
2018
Q3
Sell
-400
Closed -$9K 996
2018
Q2
$9K Buy
400
+392
+4,900% +$8.11K ﹤0.01% 625
2018
Q1
$0 Hold
8
﹤0.01% 1058
2017
Q4
$0 Buy
+8
New +$213 ﹤0.01% 1032

Other funds holding EXEL

Gradient Investments's EXEL Position: Q2 2022 in Review

Gradient Investments sold out of Exelixis (EXEL) in Q2 2022, closing a stake of 90 shares — an estimated $2K sold.

Gradient Investments first reported a position in EXEL in Q4 2017 and held it in 11 quarters. The position peaked at $9K in Q2 2018. 373 funds tracked by Wall St. Rank hold EXEL as of Q2 2022.

  • Gradient Investments reported no remaining Exelixis position as of Q2 2022 after selling out during the quarter.
  • Gradient Investments sold 90 Exelixis shares in Q2 2022, an estimated $2K.
  • Gradient Investments first reported a position in Exelixis in Q4 2017 and held it in 11 quarters.
  • Gradient Investments's Exelixis position peaked at $9K in Q2 2018.
  • 373 funds tracked by Wall St. Rank held Exelixis as of Q2 2022.

Based on Gradient Investments's 13F filing for Q2 2022, filed 11 Jul 2022.